ID   SCCF2-Luc-YFP
AC   CVCL_E6XT
SY   SCCF2Luc
DR   ABM; T6447
RX   PubMed=20959474;
RX   PubMed=22265717;
CC   Characteristics: Transfected with a luciferase-YFP fusion protein whose expression is under the control of a CMV promoter (PubMed=20959474; PubMed=22265717).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Firefly luciferase.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C132824; Feline oral squamous cell carcinoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_C4UU ! SCCF2
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   PubMed=20959474; DOI=10.1158/0008-5472.CAN-10-0850; PMCID=PMC2970642;
RA   Martin C.K., Werbeck J.L., Thudi N.K., Lanigan L.G., Wolfe T.D.,
RA   Toribio R.E., Rosol T.J.;
RT   "Zoledronic acid reduces bone loss and tumor growth in an orthotopic
RT   xenograft model of osteolytic oral squamous cell carcinoma.";
RL   Cancer Res. 70:8607-8616(2010).
//
RX   PubMed=22265717; DOI=10.1016/j.oraloncology.2011.12.012; PMCID=PMC3350825;
RA   Martin C.K., Dirksen W.P., Shu S.T., Werbeck J.L., Thudi N.K.,
RA   Yamaguchi M., Wolfe T.D., Heller K.N., Rosol T.J.;
RT   "Characterization of bone resorption in novel in vitro and in vivo
RT   models of oral squamous cell carcinoma.";
RL   Oral Oncol. 48:491-499(2012).
//